Home/KORU Medical Systems/Anna Majapuro-Hirvonen
AM

Anna Majapuro-Hirvonen

Director, Global Medical and Clinical Affairs

KORU Medical Systems

Therapeutic Areas

KORU Medical Systems Pipeline

DrugIndicationPhase
FreedomEDGE® + RYSTIGGO®Generalized Myasthenia GravisCleared
Freedom™ System + SCIgPrimary Immunodeficiencies, CIDPCommercial